Posted by Michael Wonder on 10 Dec 2019
Endo launches generic version of Afinitor (everolimus) tablets in the United States
10 December 2019 - Endo International today announced that one of its operating companies, Par Pharmaceutical, has received approval for and launched generic Afinitor (everolimus) 2.5 mg, 5 mg and 7 mg tablets.
Product is available for immediate shipping.
According to IQVIA data, sales for Afinitor 2.5 mg, 5mg and 7mg tablets were approximately $412 million over the last four quarters.
